reuters.com · 9 jul

US power companies scramble to secure equipment as surging data center demand strains supplies

Skyrocketing demand from artificial intelligence data centers is exacerbating shortages of critical grid equipment like transformers across the U.S., driving up costs, stretching out wait times and spurring utilities ​and developers to lock in orders far in advance.

prnewswire.com · 7 jul

CMS Energy to Announce 2026 Second Quarter Results on July 28

JACKSON, Mich., July 7, 2026 /PRNewswire/ -- CMS Energy announced today it will provide 2026 second quarter results along with a business and financial outlook at 10:00 a.m.

prnewswire.com · 1 jul

CMS Energy Announces Polly Harris as Vice President of Human Resources

/PRNewswire/ -- CMS Energy announced today that Polly Harris has been named vice president of human resources, effective July 20. Harris was previously with

zacks.com · 30 jun

PPL vs. CMS: Which Regulated Utility Stock is the Smarter Investment?

CMS edges PPL on ROE, capital investment plans and six-month share gains, while both utilities invest in grid upgrades and clean energy.

gurufocus.com · 24 jun

CMS Energy Announces Chris Shellberg as Vice President of Low-Voltage Electric Distribution

CMS Energy Announces Chris Shellberg as Vice President of Low-Voltage Electric Distribution PR Newswire JACKSON,

prnewswire.com · 24 jun

CMS Energy Announces Chris Shellberg as Vice President of Low-Voltage Electric Distribution

JACKSON, Mich., June 24, 2026 /PRNewswire/ -- CMS Energy announced today that Chris Shellberg has been named vice president of low-voltage electric distribution, effective July 1.

globenewswire.com · 23 jun

Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board

ARLINGTON, Va., June 23, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced the appointment of Rajiv Uppal, former Chief Information Officer of the Centers for Medicare & Medicaid Services (CMS) and the Internal Revenue Service (IRS), to the company's Advisory Board.

globenewswire.com · 22 jun

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People's Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.